Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome

Back

EHRA Premium Access

Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome

Session: Young Investigator Award: Basic and Translational Science

Topic: Clinical mechanisms (Cardiac arrhythmias, non invasive)

Speaker: Doctor D. Akdis (Zurich, CH)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Doctor Deniz Akdis

University Heart Center, Zurich (Switzerland)

0 follower

5 more presentations in this session

High risk of heart failure in desmoglein-2 mutation carriers in arrhythmogenic right ventricular dysplasia/cardiomyopathy

Speaker: Doctor A. Hermida (Paris, FR)

The antiarrhythmic effects of melatonin in different pathological conditions

Speaker: Doctor T. Egan Benova (Bratislava, SK)

Access

Abstract

Integration of noninvasive imaging of repolarization and cellular modelling for personalized medicine in primary ventricular fibrillation

Speaker: Doctor M. Cluitmans (Maastricht, NL)

Optogenetic ablation of spiral wave arrhythmias by creating light lesions

Speaker: Ms I. Feola (Leiden, NL)

Access

Abstract

Percutaneous partially-insulated epicardial tool allows low defibrillation tresholds and prevents extra-cardiac stimulation

Speaker: Doctor M. Pesl (Brno, CZ)

Access

Abstract

Access the full session

Young Investigator Award: Basic and Translational Science

Speakers: Doctor D. Akdis, Doctor A. Hermida, Doctor T. Egan Benova, Doctor M. Cluitmans, Ms I. Feola...

Access

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources